Skip to main content
. 2019 Mar 28;10:601. doi: 10.3389/fimmu.2019.00601

Figure 3.

Figure 3

Expression of proinflammatory cytokine mRNA in moDC following treatment with native or aggregated infliximab (A) and natalizumab (B). Immature moDC were treated with native or stressed (SSL2 or HSL2) antibodies. Transcripts were measured after 6 h (for IL-1β, IL-6, IL-8, and TNFα) or 24 h (for IL-12p40) using real-time RT-PCR. Results are expressed as fold change over PBS control. The results from 12 independent experiments are shown. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.